The Global Perspective of Pharmacovigilance in Nuclear Medicine Practice.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Adverse Reactions by Radiopharmaceuticals: Retrospective Analysis of the Portuguese National Pharmacovigilance System.The Annals of pharmacotherapy · 2025
   Observational
2. Pharmacovigilance of Radiopharmaceuticals: Challenges and Opportunities.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2024
   Article
3. How can we optimise the pharmaceutical analysis of radiopharmaceutical pediatric prescriptions?European journal of hospital pharmacy : science and practice · 2023
   Review
4. Ethical Conundrum in Nuclear Medicine Research in India.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
   Article
5. Review of Adverse Reactions Associated with the Use of Common Diagnostic Radiopharmaceuticals.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
   Review
6. Adverse events associated with the use of radiopharmaceuticals: A prospective study from a tertiary care institute.Perspectives in clinical research
   Article
7. A Comparative Study of Pharmacopoeial Quality Standards and Regulations of Radiopharmaceuticals.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
   Review
8. Vaccine pharmacovigilance in India: Current context and future perspective.Indian journal of pharmacology
   Article
9. Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.